GlassScriptPhysician profile
Jessica Luc
NPI 1487485017
$28,420.79
in general payments reported to CMS, 2019-2025
12 companies · $6,439 in 2025
The $6,439 reported for 2025 was more than what 85% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $22K · 2025: $6,439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $15K · Travel and Lodging: $9,357 · Food and Beverage: $3,973 · Education: $90.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $15,000.00 |
| Travel and Lodging | $9,357.13 |
| Food and Beverage | $3,972.67 |
| Education | $90.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17,488.72 | 2024-2025 | Corevalve Evolut R |
| Edwards Lifesciences Corporation | $4,860.85 | 2025 | Pascal, Sapien 3 Ultra Resilia |
| Abbott Laboratories | $2,086.20 | 2024-2025 | Mitraclip, Navitor |
| Atricure, INC. | $1,856.39 | 2024-2025 | Atriclip Laa Exclusion System |
| Boston Scientific Corporation | $1,561.78 | 2024-2025 | Versacross Access Solution |
| Shockwave Medical, INC | $242.61 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $122.18 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Corcym INC | $67.41 | 2025 | Perceval |
| Cook Medical LLC | $52.63 | 2025 | Zilver Ptx |
| Novo Nordisk INC | $50.00 | 2025 | Wegovy |
| W. L. Gore & Associates, INC. | $17.21 | 2025 | Gore Tag Conformable Thoracic Endoprosthesis |
| Hologic Sales and Service, LLC | $14.81 | 2024 | Novasure, Myosure Tissue Removal Device |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Luc listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.